PGEN Precigen Inc

Price (delayed)

$4.57

Market cap

$944.36M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.6

Enterprise value

$1.1B

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases ...

Highlights
Precigen's EPS has surged by 71% YoY and by 21% QoQ
PGEN's net income has surged by 66% year-on-year and by 18% since the previous quarter
PGEN's quick ratio has soared by 100% YoY but it is down by 2.4% from the previous quarter
Precigen's debt has decreased by 23% YoY but it has increased by 3.8% from the previous quarter
PGEN's equity is down by 9% since the previous quarter

Key stats

What are the main financial stats of PGEN
Market
Shares outstanding
206.64M
Market cap
$944.36M
Enterprise value
$1.1B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.93
Price to sales (P/S)
9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.88
Earnings
Revenue
$101.01M
EBIT
-$90.23M
EBITDA
-$75.26M
Free cash flow
-$57.12M
Per share
EPS
-$0.6
Free cash flow per share
-$0.29
Book value per share
$0.77
Revenue per share
$0.51
TBVPS
$1.45
Balance sheet
Total assets
$402.57M
Total liabilities
$243.38M
Debt
$191.04M
Equity
$159.2M
Working capital
$127.82M
Liquidity
Debt to equity
1.2
Current ratio
5.43
Quick ratio
4.91
Net debt/EBITDA
-2.05
Margins
EBITDA margin
-74.5%
Gross margin
45.6%
Net margin
-107.5%
Operating margin
-54.8%
Efficiency
Return on assets
-29.7%
Return on equity
-94.4%
Return on invested capital
-24.1%
Return on capital employed
-24.1%
Return on sales
-89.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGEN stock price

How has the Precigen stock price performed over time
Intraday
-0.44%
1 week
-3.18%
1 month
-13.61%
1 year
4.1%
YTD
-55.2%
QTD
-8.42%

Financial performance

How have Precigen's revenue and profit performed over time
Revenue
$101.01M
Gross profit
$46.02M
Operating income
-$55.34M
Net income
-$108.54M
Gross margin
45.6%
Net margin
-107.5%
Precigen's net margin has soared by 68% YoY and by 20% from the previous quarter
PGEN's net income has surged by 66% year-on-year and by 18% since the previous quarter
PGEN's operating margin has soared by 52% YoY but it is down by 4.6% from the previous quarter
Precigen's operating income has increased by 49% YoY but it has decreased by 8% from the previous quarter

Growth

What is Precigen's growth rate over time

Valuation

What is Precigen stock price valuation
P/E
N/A
P/B
5.93
P/S
9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.88
Precigen's EPS has surged by 71% YoY and by 21% QoQ
PGEN's P/B is 57% below its last 4 quarters average of 13.8 and 18% below its 5-year quarterly average of 7.2
PGEN's equity is down by 9% since the previous quarter
PGEN's P/S is 26% below its last 4 quarters average of 12.2 and 11% below its 5-year quarterly average of 10.1
Precigen's revenue has increased by 6% YoY and by 3.2% from the previous quarter

Efficiency

How efficient is Precigen business performance
Precigen's return on sales has surged by 72% YoY and by 23% QoQ
PGEN's return on equity has surged by 68% year-on-year and by 37% since the previous quarter
The ROIC has soared by 67% YoY and by 22% from the previous quarter
The ROA has soared by 58% YoY and by 20% from the previous quarter

Dividends

What is PGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGEN.

Financial health

How did Precigen financials performed over time
The company's total assets is 65% higher than its total liabilities
PGEN's current ratio has surged by 101% year-on-year but it is down by 4.9% since the previous quarter
PGEN's quick ratio has soared by 100% YoY but it is down by 2.4% from the previous quarter
Precigen's debt is 20% more than its equity
PGEN's debt to equity has plunged by 76% YoY but it is up by 14% from the previous quarter
Precigen's debt has decreased by 23% YoY but it has increased by 3.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.